Matthew Sean Marengo

This inventor holds 9 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Monsanto Technology LLC, Duke University. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Sean Marengo. Retrieved from https://idiyas.com/inventor/matthew-sean-marengo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 16(Granted Patents)

Location History:

Durham, NC (US) (2017)
St. Louis, MO (US) (2019)
Cary, NC (US) (2016 - 2022)
Wildwood, MO (US) (2023 - 2024)

Company Filing History:

6 out of 7,312

Monsanto Technology LLC

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545920 - INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING MEIOTIC AND GERMLINE PROMOTERS (2026-02-10),

2. 12467056 - PLANT REGULATORY ELEMENTS AND USES THEREOF (2025-11-11),

3. 12392000 - Methods and compositions for producing brachytic corn plants (2025-08-19),

4. 11981900 - Increasing gene editing and site-directed integration events utilizing meiotic and germline promoters (2024-05-14),

5. 11825850 - Insect inhibitory proteins (2023-11-28),

6. 11214842 - Methods and compositions for producing brachytic corn plants (2022-01-04),

7. 10472684 - Methods and compositions for producing brachytic corn plants (2019-11-12),

8. 9845481 - Synthetic regulation of gene expression (2017-12-19),

9. 9284575 - Synthetic regulation of gene expression (2016-03-15),

Title: The Innovative Contributions of Matthew Sean Marengo

Introduction

Matthew Sean Marengo is a distinguished inventor based in Cary, NC, with a notable portfolio comprising six patents. His work primarily focuses on advancements in genetic engineering and pest control, significantly impacting agricultural and biotechnological fields.

Latest Patents

One of Marengo's latest patents is centered around increasing gene editing and site-directed integration events utilizing meiotic and germline promoters. This innovation includes methods and compositions that enhance genome editing through guided endonucleases and various cell-preferred promoters. Another significant patent involves insect inhibitory proteins, which detail pesticidal proteins that exhibit toxic activity against Lepidopteran pest species. The patent includes various proteins like TIC4029, TIC4029_1, and TIC4029_8, along with DNA constructs that contain recombinant nucleic acid sequences. These advancements also describe methods for detecting the presence of these proteins and controlling pest species effectively.

Career Highlights

Marengo has contributed to several reputable organizations in the biotechnology sector, notably at Monsanto Technology LLC and Duke University. His roles in these companies allowed him to apply his expertise in developing innovative solutions that respond to agricultural challenges, aiming for improved crop protection.

Collaborations

Throughout his career, Marengo has collaborated with esteemed peers such as Mariano A. Garcia-Blanco and Ty Jason Barten. These partnerships have fostered an environment of innovation, leading to the development of groundbreaking technologies in his field.

Conclusion

Matthew Sean Marengo's work as an inventor exemplifies a commitment to enhancing agricultural practices through innovative technologies. His patents not only provide robust solutions for pest control but also push the boundaries of genetic engineering, ensuring food security and sustainability in an ever-evolving world.

Profile summary based on public USPTO records.